Development of improved pertussis vaccine

References

• Cherry JD, Seaton BL. Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010. Clin Infect Dis 2012; 54:534 - 7; http://dx.doi.org/10.1093/cid/cir860; PMID: 22156857
   PubMed Web of Science ®Google Scholar
• David S, van Furth R, Mooi FR. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model. Vaccine 2004; 22:1892 - 8; http://dx.doi.org/10.1016/j.vaccine.2003.11.005; PMID: 15121300
   PubMed Web of Science ®Google Scholar
• Halperin SA. The control of pertussis--2007 and beyond. N Engl J Med 2007; 356:110 - 3; http://dx.doi.org/10.1056/NEJMp068288; PMID: 17215528
   PubMed Web of Science ®Google Scholar
• Libster R, Edwards KM. Re-emergence of pertussis: what are the solutions?. Expert Rev Vaccines 2012; 11:1331 - 46; http://dx.doi.org/10.1586/erv.12.118; PMID: 23249233
   PubMed Web of Science ®Google Scholar
• Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE, EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005; 24:761 - 5; http://dx.doi.org/10.1097/01.inf.0000177282.53500.77; PMID: 16148840
   PubMed Web of Science ®Google Scholar
• Fisman DN, Tang P, Hauck T, Richardson S, Drews SJ, Low DE, Jamieson F. Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling. BMC Public Health 2011; 11:694; http://dx.doi.org/10.1186/1471-2458-11-694; PMID: 21899765
   PubMed Web of Science ®Google Scholar
• Rodgers L, Martin SW, Cohn A, Budd J, Marcon M, Terranella A, Mandal S, Salamon D, Leber A, Tondella ML, et al. Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. Clin Infect Dis 2013; 56:322 - 31; http://dx.doi.org/10.1093/cid/cis888; PMID: 23087388
   PubMed Web of Science ®Google Scholar
• Cagney M, MacIntyre CR, McIntyre P, Puech M, Giammanco A. The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiol Infect 2006; 134:1208 - 16; http://dx.doi.org/10.1017/S095026880600625X; PMID: 16690000
   PubMed Web of Science ®Google Scholar
• Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014; 209:978 - 81; http://dx.doi.org/10.1093/infdis/jiu001; PMID: 24626532
   PubMed Web of Science ®Google Scholar
• Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85:385 - 400; PMID: 20939150
   PubMedGoogle Scholar
• Hozbor D, Mooi F, Flores D, Weltman G, Bottero D, Fossati S, Lara C, Gaillard ME, Pianciola L, Zurita E, et al. Pertussis epidemiology in Argentina: trends over 2004-2007. J Infect 2009; 59:225 - 31; http://dx.doi.org/10.1016/j.jinf.2009.07.014; PMID: 19651156
   PubMed Web of Science ®Google Scholar
• Cherry JD. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease. N Engl J Med 2012; 367:785 - 7; http://dx.doi.org/10.1056/NEJMp1209051; PMID: 22894554
   PubMed Web of Science ®Google Scholar
• McCarthy M. Acellular vaccines provided less protection during California pertussis outbreak. BMJ 2013; 346:f3325; http://dx.doi.org/10.1136/bmj.f3325; PMID: 23694748
   PubMedGoogle Scholar
• (CDC). Pertussis (Whooping Cough): Surveillance & Reporting. Centers for Disease Control and Prevention Web site Available at: http://wwwcdcgov/pertussis/surv-reportinghtml assesed 2013.
   Google Scholar
• Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 2008; 9:201 - 11, quiz 211-2; http://dx.doi.org/10.1016/j.prrv.2008.05.010; PMID: 18694712
   PubMed Web of Science ®Google Scholar
• Mooi FRNA, Van Der Maas NA, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect 2014; 142:685 - 94; http://dx.doi.org/10.1017/S0950268813000071; PMID: 23406868
   PubMed Web of Science ®Google Scholar
• Girard DZ. Recommended or mandatory pertussis vaccination policy in developed countries: does the choice matter?. Public Health 2012; 126:117 - 22; http://dx.doi.org/10.1016/j.puhe.2011.11.007; PMID: 22226337
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24:Suppl S58 - 61; http://dx.doi.org/10.1097/01.inf.0000160914.59160.41; PMID: 15876927
   PubMedGoogle Scholar
• ACOG Committee Opinion No. ACOG Committee Opinion No. 566: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol 2013; 121:1411 - 4; http://dx.doi.org/10.1097/01.AOG.0000431054.33593.e3; PMID: 23812487
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1424 - 6; PMID: 22012116
   PubMedGoogle Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014; 111:787 - 92; http://dx.doi.org/10.1073/pnas.1314688110; PMID: 24277828
   PubMed Web of Science ®Google Scholar
• Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013; 131:e1716 - 22; http://dx.doi.org/10.1542/peds.2012-3836; PMID: 23690518
   PubMed Web of Science ®Google Scholar
• Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012; 54:1730 - 5; http://dx.doi.org/10.1093/cid/cis287; PMID: 22423127
   PubMed Web of Science ®Google Scholar
• Witt MA, Arias L, Katz PH, Truong ET, Witt DJ. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 2013; 56:1248 - 54; http://dx.doi.org/10.1093/cid/cit046; PMID: 23487373
   PubMed Web of Science ®Google Scholar
• Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013; 9:e1003264; http://dx.doi.org/10.1371/journal.ppat.1003264; PMID: 23592988
   PubMed Web of Science ®Google Scholar
• Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 2013; 6:787 - 96; http://dx.doi.org/10.1038/mi.2012.117; PMID: 23187316
   PubMed Web of Science ®Google Scholar
• Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 2014; 5:e01074; http://dx.doi.org/10.1128/mBio.01074-14; PMID: 24757216
   PubMed Web of Science ®Google Scholar
• Quinlan T, Musser KA, Currenti SA, Zansky SM, Halse TA. Pertactin-negative variants of Bordetella pertussis in New York State: A retrospective analysis, 2004-2013. Mol Cell Probes 2013; 28:138 - 40; PMID: 24365130
   PubMed Web of Science ®Google Scholar
• Bodilis H, Guiso N. Virulence of pertactin-negative Bordetella pertussis isolates from infants, France. Emerg Infect Dis 2013; 19:471 - 4; http://dx.doi.org/10.3201/eid1903.121475; PMID: 23621904
   PubMed Web of Science ®Google Scholar
• Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, Williams MM, Bowden KE, Burgos-Rivera B, Qin X, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014; 21:119 - 25; http://dx.doi.org/10.1128/CVI.00717-13; PMID: 24256623
   PubMed Web of Science ®Google Scholar
• Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, McIntyre P, Marshall H, Guiso N, Keil AD, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis 2014; 20:626 - 33; http://dx.doi.org/10.3201/eid2004.131478; PMID: 24655754
   PubMed Web of Science ®Google Scholar
• Bokhari H, Said F, Syed MA, Mughal A, Kazi YF, Heuvelman K, Mooi FR. Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009. Scand J Infect Dis 2011; 43:818 - 20; http://dx.doi.org/10.3109/00365548.2011.577804; PMID: 21563881
   PubMed Web of Science ®Google Scholar
• Watanabe M, Nagai M. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2004; 2:447 - 54; http://dx.doi.org/10.1586/14787210.2.3.447; PMID: 15482209
   PubMedGoogle Scholar
• Dias WO, van der Ark AA, Sakauchi MA, Kubrusly FS, Prestes AF, Borges MM, Furuyama N, Horton DS, Quintilio W, Antoniazi M, et al. An improved whole cell pertussis vaccine with reduced content of endotoxin. Hum Vaccin Immunother 2013; 9; http://dx.doi.org/10.4161/hv.22847; PMID: 23291935
   PubMed Web of Science ®Google Scholar
• Thalen M, Venema M, van den IJssel J, Berwald L, Beuvery C, Martens D, Tramper J. Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis. Biologicals 2006; 34:213 - 20; http://dx.doi.org/10.1016/j.biologicals.2005.11.002; PMID: 16497513
   PubMed Web of Science ®Google Scholar
• Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol 2010; 185:1711 - 9; http://dx.doi.org/10.4049/jimmunol.1000105; PMID: 20610650
   PubMed Web of Science ®Google Scholar
• Alvarez Hayes J, Erben E, Lamberti Y, Principi G, Maschi F, Ayala M, Rodriguez ME. Bordetella pertussis iron regulated proteins as potential vaccine components. Vaccine 2013; 31:3543 - 8; http://dx.doi.org/10.1016/j.vaccine.2013.05.072; PMID: 23731630
   PubMed Web of Science ®Google Scholar
• Mills KH, Ross PJ, Allen AC, Wilk MM. Do we need a new vaccine to control the re-emergence of pertussis?. Trends Microbiol 2014; 22:49 - 52; PMID: 24485284
   PubMed Web of Science ®Google Scholar
• Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, Creusy C, Engle J, Goldman WE, Locht C. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2006; 2:e65; http://dx.doi.org/10.1371/journal.ppat.0020065; PMID: 16839199
   PubMed Web of Science ®Google Scholar
• Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergström J, Ljungman M, Törner A, Wehlin L, Van Broekhoven A, Bosman F, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One 2014; 9:e83449; http://dx.doi.org/10.1371/journal.pone.0083449; PMID: 24421886
   PubMed Web of Science ®Google Scholar
• Schnoeller C, Roux X, Sawant D, Raze D, Olszewska W, Locht C, Openshaw PJ. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Am J Respir Crit Care Med 2014; 189:194 - 202; PMID: 24261996
   PubMed Web of Science ®Google Scholar
• Li R, Cheng C, Chong SZ, Lim AR, Goh YF, Locht C, Kemeny DM, Angeli V, Wong WS, Alonso S. Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models. Allergy 2012; 67:1250 - 8; http://dx.doi.org/10.1111/j.1398-9995.2012.02884.x; PMID: 22909095
   PubMed Web of Science ®Google Scholar
• Holst J, Martin D, Arnold R, Huergo CC, Oster P, O’Hallahan J, Rosenqvist E. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 2009; 27:Suppl 2 B3 - 12; http://dx.doi.org/10.1016/j.vaccine.2009.04.071; PMID: 19481313
   PubMed Web of Science ®Google Scholar
• Holst J, Oster P, Arnold R, Tatley MV, Næss LM, Aaberge IS, Galloway Y, McNicholas A, O’Hallahan J, Rosenqvist E, et al. Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother 2013; 9:1241 - 53; http://dx.doi.org/10.4161/hv.24129; PMID: 23857274
   PubMed Web of Science ®Google Scholar
• Asensio CJ, Gaillard ME, Moreno G, Bottero D, Zurita E, Rumbo M, van der Ley P, van der Ark A, Hozbor D. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate. Vaccine 2011; 29:1649 - 56; http://dx.doi.org/10.1016/j.vaccine.2010.12.068; PMID: 21211579
   PubMed Web of Science ®Google Scholar
• Bottero D, Gaillard ME, Errea A, Moreno G, Zurita E, Pianciola L, Rumbo M, Hozbor D. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection. Vaccine 2013; 31:5262 - 8; http://dx.doi.org/10.1016/j.vaccine.2013.08.059; PMID: 24012570
   PubMed Web of Science ®Google Scholar
• Roberts R, Moreno G, Bottero D, Gaillard ME, Fingermann M, Graieb A, Rumbo M, Hozbor D. Outer membrane vesicles as acellular vaccine against pertussis. Vaccine 2008; 26:4639 - 46; http://dx.doi.org/10.1016/j.vaccine.2008.07.004; PMID: 18640169
   PubMed Web of Science ®Google Scholar
• Gaillard ME, Bottero D, Errea A, Ormazábal M, Zurita ME, Moreno G, Rumbo M, Castuma C, Bartel E, Flores D, et al. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes. Vaccine 2014; 32:931 - 7; http://dx.doi.org/10.1016/j.vaccine.2013.12.048; PMID: 24397896
   PubMed Web of Science ®Google Scholar